56796-66-8 Usage
Description
4-(benzyloxy)-alpha-[[tert-butylamino]methyl]-m-xylene-alpha,alpha'-diol is a complex organic compound with a unique molecular structure. It is characterized by the presence of a benzyloxy group, a tert-butylamino group, and a m-xylene backbone with two hydroxyl groups. 4-(benzyloxy)-alpha-[[tert-butylamino]methyl]-m-xylene-alpha,alpha'-diol has potential applications in various industries due to its chemical properties.
Uses
Used in Pharmaceutical Industry:
4-(benzyloxy)-alpha-[[tert-butylamino]methyl]-m-xylene-alpha,alpha'-diol is used as a Salbutamol precursor for the synthesis of 4-Benzyl Albuterol. Salbutamol, also known as albuterol, is a medication used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. It works by relaxing the muscles in the airways, providing relief from breathing difficulties.
Additionally, 4-(benzyloxy)-alpha-[[tert-butylamino]methyl]-m-xylene-alpha,alpha'-diol is used as an impurity in the production of Rosiglitazone Maleate Imp A. Rosiglitazone is an oral medication used to treat type 2 diabetes by improving the body's sensitivity to insulin. The presence of this compound as an impurity helps in the quality control and standardization of the final pharmaceutical product.
Check Digit Verification of cas no
The CAS Registry Mumber 56796-66-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,7,9 and 6 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 56796-66:
(7*5)+(6*6)+(5*7)+(4*9)+(3*6)+(2*6)+(1*6)=178
178 % 10 = 8
So 56796-66-8 is a valid CAS Registry Number.
56796-66-8Relevant articles and documents
A chromatography-free synthesis of racemic salbutamol hemisulfate
Vanoost, Agathe,Petit, Laurent
, (2020/06/30)
Our efforts to achieve an efficient synthesis of racemic salbutamol hemisulfate are described. The selected chemical route starts from commodity chemicals and allows the generation of salbutamol hemisulfate in 5 steps and 44% overall yield without any purification by column chromatography. The reaction sequence has been optimized to provide the title compound using robust procedures. Emphasis on reproducibility and experimental simplicity drove the work described herein.